Status:
COMPLETED
Nexplanon Observational Risk Assessment Study (NORA)
Lead Sponsor:
Center for Epidemiology and Health Research, Germany
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Contraception
Eligibility:
FEMALE
12+ years
Brief Summary
This study characterises the frequency of specific insertion-, localization- and removal-related events and clinically significant consequences thereof among Nexplanon users in the US during routine c...
Detailed Description
Nexplanon is a subdermal contraceptive implant containing the progestogen etonogestrel. It provides contraceptive protection for three years. In addition to the progestogen, Nexplanon contains barium ...
Eligibility Criteria
Inclusion
- Women prescribed a new Nexplanon implant
- Women who are capable of understanding the major aspects of the study and can complete the self-administered questionnaire in English
Exclusion
- Women who are not willing to sign the informed consent form
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2017
Estimated Enrollment :
7364 Patients enrolled
Trial Details
Trial ID
NCT01473641
Start Date
November 1 2011
End Date
October 31 2017
Last Update
November 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Epidemiology and Health Research
Berlin, Germany